Dr. Ashish Ranjan Dwivedi is a distinguished academic in the field of medicinal chemistry, with a focus on the synthesis of small heterocyclic molecules and their evaluation as potential treatments for cancer and neurological disorders. Currently serving as an Assistant Professor at the Gandhi Institute of Technology and Management, Dr. Dwivedi's contributions to the scientific community are reflected in his numerous publications, highlighting his expertise and dedication to research.
Research Publications
A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the “industrial” perspective.
Synthesis and screening of novel 4-N-heterocyclic-2-aryl-6, 7, 8-trimethoxyquinazolines as antiproliferative and tubulin polymerization inhibitors
Caesium carbonate promoted regioselective O-functionalization of 4, 6-diphenylpyrimidin-2 (1 H)-ones under mild conditions and mechanistic insight
Iodine-PEG as a unique combination for the metal-free synthesis of flavonoids through iodonium-triiodide ion-pair complexation
Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer’s Disease
Authored Books
Clinical trials, regulatory considerations, and market overview of antibiotics
Expertise
Design and synthesis of small heterocyclic molecules targeting Cancer and Neurological Disorder
Anticancer profiling like cytotoxicity, apoptosis, necrosis of synthesized compounds
| 
| 
| 
